OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Iosifina Foskolou, PhD, is a group leader at Sanquin Institute (Amsterdam), specialising in T cell metabolism and cancer immunotherapy. Her lab focuses on improving T cell immunotherapies against solid tumours by better understanding the environments immune cells face in both the tumour microenvironment and lymphoid tissues.
Iosifina holds a DPhil in Oncology from the University of Oxford, where she studied the effects of low oxygen (hypoxia) in solid tumours. She has extensive postdoctoral experience at both Cambridge University and the Karolinska Institute, where she investigated how metabolism can improve cancer immunotherapy.
Iosifina has a robust academic background, and her work has been widely published in peer-reviewed journals, with key papers on T cell function, metabolism, and anti-tumour immunity. Throughout her career, she has secured numerous grants, including a Marie Sklodowska Curie post-doctoral Fellowship.
